Cargando…
Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience
Endometrial cancer (EC) is the most common malignant tumor of the female reproductive tract in developed countries and the second most common gynecologic malignancy in China. Although EC is most often diagnosed in postmenopausal women, the increase in obesity rates and other lifestyle changes has be...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289121/ https://www.ncbi.nlm.nih.gov/pubmed/30584372 http://dx.doi.org/10.2147/CMAR.S188087 |
_version_ | 1783379926456467456 |
---|---|
author | Wang, Yao Yang, Jia-xin |
author_facet | Wang, Yao Yang, Jia-xin |
author_sort | Wang, Yao |
collection | PubMed |
description | Endometrial cancer (EC) is the most common malignant tumor of the female reproductive tract in developed countries and the second most common gynecologic malignancy in China. Although EC is most often diagnosed in postmenopausal women, the increase in obesity rates and other lifestyle changes has been accompanied by an increase in the prevalence of EC among younger women. Approximately 4% of patients are diagnosed before the age of 40 years and before having given birth. Such patients may have a strong desire to preserve their fertility despite oncologic risks and thus may be reluctant to undergo standard treatment for EC, which includes hysterectomy, bilateral salpingo-oophorectomy, and surgical staging. Therefore, more conservative treatment approaches may need to be discussed, along with their associated oncologic and reproductive outcomes. In fact, various studies have confirmed the effectiveness and safety of conservative treatment in EC. This review aimed to provide a concise yet informative overview of the current status of fertility-preserving treatment for EC in China, as well as to summarize the latest and ongoing research efforts in this area. |
format | Online Article Text |
id | pubmed-6289121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62891212018-12-24 Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience Wang, Yao Yang, Jia-xin Cancer Manag Res Review Endometrial cancer (EC) is the most common malignant tumor of the female reproductive tract in developed countries and the second most common gynecologic malignancy in China. Although EC is most often diagnosed in postmenopausal women, the increase in obesity rates and other lifestyle changes has been accompanied by an increase in the prevalence of EC among younger women. Approximately 4% of patients are diagnosed before the age of 40 years and before having given birth. Such patients may have a strong desire to preserve their fertility despite oncologic risks and thus may be reluctant to undergo standard treatment for EC, which includes hysterectomy, bilateral salpingo-oophorectomy, and surgical staging. Therefore, more conservative treatment approaches may need to be discussed, along with their associated oncologic and reproductive outcomes. In fact, various studies have confirmed the effectiveness and safety of conservative treatment in EC. This review aimed to provide a concise yet informative overview of the current status of fertility-preserving treatment for EC in China, as well as to summarize the latest and ongoing research efforts in this area. Dove Medical Press 2018-12-07 /pmc/articles/PMC6289121/ /pubmed/30584372 http://dx.doi.org/10.2147/CMAR.S188087 Text en © 2018 Wang and Yang. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Wang, Yao Yang, Jia-xin Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience |
title | Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience |
title_full | Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience |
title_fullStr | Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience |
title_full_unstemmed | Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience |
title_short | Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience |
title_sort | fertility-preserving treatment in women with early endometrial cancer: the chinese experience |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289121/ https://www.ncbi.nlm.nih.gov/pubmed/30584372 http://dx.doi.org/10.2147/CMAR.S188087 |
work_keys_str_mv | AT wangyao fertilitypreservingtreatmentinwomenwithearlyendometrialcancerthechineseexperience AT yangjiaxin fertilitypreservingtreatmentinwomenwithearlyendometrialcancerthechineseexperience |